Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.1000
+0.0020 (2.04%)
Aug 28, 2026, 10:15 AM AEST
Rhythm Biosciences Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 3.36 | 1.4 | 0.71 | 4.12 | 7.55 |
Short-Term Investments | 0.09 | 0.09 | 0.05 | 0.05 | 0.05 |
Cash & Short-Term Investments | 3.44 | 1.48 | 0.75 | 4.17 | 7.6 |
Cash Growth | 132.10% | 96.45% | -81.90% | -45.11% | 234.10% |
Accounts Receivable | 0.06 | 0.06 | 0.04 | - | - |
Other Receivables | - | - | - | 0.07 | 0.08 |
Receivables | 0.06 | 0.06 | 0.04 | 0.07 | 0.08 |
Inventory | 0.02 | 0.07 | - | 2.77 | - |
Prepaid Expenses | 0.24 | 0.19 | 0.09 | 0.12 | 0.09 |
Total Current Assets | 3.76 | 1.81 | 0.89 | 7.12 | 7.77 |
Property, Plant & Equipment | 0.21 | 0.17 | 0.28 | 0.19 | 0.24 |
Goodwill | - | 0.53 | - | - | - |
Other Intangible Assets | 0.81 | 0.32 | 0.35 | 0.39 | 0.43 |
Total Assets | 4.78 | 2.83 | 1.52 | 7.7 | 8.44 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 0.64 | 0.53 | 0.21 | 1.33 | 0.28 |
Accrued Expenses | - | 0.52 | 0.27 | 0.35 | 0.57 |
Current Portion of Long-Term Debt | 0.09 | 1 | - | - | - |
Current Portion of Leases | 0.09 | 0.11 | 0.08 | 0.08 | 0.09 |
Other Current Liabilities | 0.23 | - | - | - | - |
Total Current Liabilities | 1.04 | 2.16 | 0.56 | 1.77 | 0.93 |
Long-Term Leases | 0.08 | 0 | 0.09 | - | 0.08 |
Other Long-Term Liabilities | 0.02 | 0.01 | 0 | 0.06 | 0.05 |
Total Liabilities | 1.14 | 2.17 | 0.65 | 1.82 | 1.07 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 44.96 | 37.75 | 34.45 | 31.55 | 27.83 |
Retained Earnings | -48.43 | -42.5 | -38.67 | -31.82 | -23.6 |
Comprehensive Income & Other | 7.11 | 5.41 | 5.09 | 6.14 | 3.14 |
Shareholders' Equity | 3.64 | 0.66 | 0.87 | 5.87 | 7.37 |
Total Liabilities & Equity | 4.78 | 2.83 | 1.52 | 7.7 | 8.44 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.25 | 1.11 | 0.16 | 0.08 | 0.17 |
Net Cash (Debt) | 3.19 | 0.37 | 0.59 | 4.08 | 7.43 |
Net Cash Growth | 751.42% | -36.52% | -85.54% | -44.99% | 226.62% |
Net Cash Per Share | 0.01 | 0.00 | 0.00 | 0.02 | 0.04 |
Filing Date Shares Outstanding | 352.15 | 284.08 | 248.6 | 220.92 | 214.18 |
Total Common Shares Outstanding | 352.15 | 290.33 | 248.6 | 219.79 | 214.18 |
Working Capital | 2.72 | -0.35 | 0.32 | 5.35 | 6.84 |
Book Value Per Share | 0.01 | 0.00 | 0.00 | 0.03 | 0.03 |
Tangible Book Value | 2.82 | -0.19 | 0.51 | 5.48 | 6.95 |
Tangible Book Value Per Share | 0.01 | -0.00 | 0.00 | 0.02 | 0.03 |
Machinery | - | - | - | 0.37 | 0.28 |